Literature DB >> 24680490

Medical management of adult headache.

Frederick G Freitag1, Fallon Schloemer2.   

Abstract

We review the therapies for primary headache disorders: migraine, chronic migraine, tension-type headache, and cluster headache. Recommendations follow the evidence-based treatments so far as is possible with expert opinion to give clinical guidance. Headache has 2 levels of care: acute treatments designed to stop a headache from progressing and alleviate all symptoms associated with the headache and preventive therapies for patients whose headache frequency is such that by itself produces significant disability and impact on quality of life, or where the frequency of use of acute medications, regardless of efficacy, poses risks in terms of overuse or adverse events.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Analgesics; Anti-epileptic drugs; Beta blockers; Natural therapies; Nonsteroidal anti-inflammatory drugs; Triptans; US consortium guideline

Mesh:

Substances:

Year:  2013        PMID: 24680490     DOI: 10.1016/j.otc.2013.11.002

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  6 in total

1.  Cost-effectiveness of stimulation of the sphenopalatine ganglion (SPG) for the treatment of chronic cluster headache: a model-based analysis based on the Pathway CH-1 study.

Authors:  Jan B Pietzsch; Abigail Garner; Charly Gaul; Arne May
Journal:  J Headache Pain       Date:  2015-05-21       Impact factor: 7.277

2.  Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache.

Authors:  James Morris; Andreas Straube; Hans-Christoph Diener; Fayyaz Ahmed; Nicholas Silver; Simon Walker; Eric Liebler; Charly Gaul
Journal:  J Headache Pain       Date:  2016-04-22       Impact factor: 7.277

3.  Effects of non-invasive vagus nerve stimulation on attack frequency over time and expanded response rates in patients with chronic cluster headache: a post hoc analysis of the randomised, controlled PREVA study.

Authors:  Charly Gaul; Delphine Magis; Eric Liebler; Andreas Straube
Journal:  J Headache Pain       Date:  2017-02-14       Impact factor: 7.277

4.  Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine.

Authors:  Janet H Ford; Shonda A Foster; Virginia L Stauffer; Dustin D Ruff; Sheena K Aurora; Jan Versijpt
Journal:  Patient Prefer Adherence       Date:  2018-11-13       Impact factor: 2.711

Review 5.  New Approaches to Shifting the Migraine Treatment Paradigm.

Authors:  Brian Johnson; Frederick G Freitag
Journal:  Front Pain Res (Lausanne)       Date:  2022-09-06

6.  The psychometric properties of the Comprehensive Headache-related Quality of life Questionnaire (CHQQ) translated to Serbian.

Authors:  Slobodan M Jankovic; Marija Andjelkovic; Radica Zivkovic Zaric; Marko Vasic; Éva Csépány; Tamás Gyüre; Csaba Ertsey
Journal:  Springerplus       Date:  2016-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.